Rapamycin and Dalotuzumab in combination inhibit parental and endocrine resistant breast cancer cells.

被引：0
|
作者：
Beckwith, H. [1 ]
Fettig-Anderson, L. [1 ]
Yueh, N. [1 ]
Douglas, Y. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P4-07-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-07-03
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effect of cholesterol depletion in resistant breast cancer cells.
    Villeda, Virgilio Alexander
    Benakanakere, Indira
    Freter, Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Neratinib to inhibit the growth of triple-negative breast cancer cells.
    Mullooly, Maeve
    Conklin, Dylan
    McGowan, Patricia M.
    O'Brien, Neil A.
    O'Donovan, Norma
    Slamon, Dennis J.
    Crown, John
    Finn, Richard S.
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Curcumin Modulates Tamoxifen Response in Resistant Breast Cancer Cells.
    De Gasperi, M. J.
    Cavazos, D.
    deGraffenried, L. A.
    CANCER RESEARCH, 2009, 69 (24) : 679S - 679S
  • [4] A Phase II Study of the Combination of Endocrine Treatment and Bortezomib in Patients with Endocrine Resistant Metastatic Breast Cancer
    Trinh, X. B.
    Van Laere, S. J.
    Deleu, I
    van de Velde, H.
    Van der Auwer, I
    Limame, R.
    Wojtasik, A.
    Maes, H.
    De Mesmaeker, P.
    van Dam, P. A.
    Prove, A.
    Vandebroek, J.
    Rasschaert, M.
    Vermeulen, P. B.
    Dirix, L. Y.
    CANCER RESEARCH, 2009, 69 (24) : 739S - 740S
  • [5] The Combination of Rapamycin and Resveratrol Blocks Autophagy and Induces Apoptosis in Breast Cancer Cells
    Alayev, Anya
    Berger, Sara Malka
    Kramer, Melissa Y.
    Schwartz, Naomi S.
    Holz, Marina K.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (03) : 450 - 457
  • [6] HNRNPA2B1 increases the serine synthesis pathway in endocrine-resistant breast cancer cells.
    Klinge, Carolyn M.
    Petri, Belinda J.
    Piell, Kellianne M.
    Clem, Brian C.
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Mammalian Target of Rapamycin Inhibition Synergistically Increases Cytotoxicity of Vinorelbine in Breast Cancer Cells.
    Audet, Robert M.
    Alami, Nezha
    Banerjee, Kris
    Leyland-Jones, Brian
    CANCER RESEARCH, 2006, 66 (08)
  • [8] The diverse sensitivity of parental and resistant breast cancer cells after electrochemotherapeutic
    Rembialkowska, N.
    Choromanska, A.
    Dubinska-Magiera, M.
    Rossowska, J.
    Kotulska, M.
    Saczko, J.
    Mir, L. M.
    Kulbacka, J.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S289 - S289
  • [9] Effect of alkaline pH on endocrine-resistant breast cancer cells
    Khajah, Maitham A.
    Mathew, Princy M.
    Alam-Eldin, Nada S.
    Luqmani, Yunus A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S8 - S8
  • [10] A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer
    Trinh, X. B.
    Sas, L.
    Van Laere, S. J.
    Prove, A.
    Deleu, I.
    Rasschaert, M. A.
    Van de Velde, H.
    Vinken, P.
    Vermeulen, P. B.
    van Dam, P. A.
    Wojtasik, A.
    De Mesmaeker, P.
    Tjalma, W. A.
    Dirix, L. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345